GGrantIndex
Sort

15,842 grants matching pancreatic cancer

Magnetic resonance Imaging as a Non-Invasive Method for Assessment of Pancreatic fibrosis (MINIMAP): a pilot study

$619,079
Evan L Fogel · Indiana University Indianapolis · R01 · FY2020 · DK

Protein and proteolytic activity biomarkers of early stage pancreatic cancer

$618,868
Paul Tempst · Sloan-Kettering Inst Can Research · R01 · FY2018 · CA

Harnessing TNFa Signaling To Improve Therapeutic Response In Pancreatic Cancer

$618,273
Kian H Lim · Washington University · R01 · FY2023 · CA

Targeted Molecular Imaging of Plectin-1; Bench to bedside and back again

$617,985
Julie L Sutcliffe · University Of California At Davis · R01 · FY2018 · CA

Prospective immune profiling using methylation markers and pancreatic cancer risk

$617,928
Dominique S Michaud · Tufts University Boston · R01 · FY2016 · CA

Subpopulations of Pancreatic Cancer Cells Defined by Glycan Markers

$617,734
Brian B Haab · Van Andel Research Institute · U01 · FY2019 · CA

Stromal and vascular inputs into pancreatic cancer tumor neighborhoods

$617,725
Ben Z Stanger · University Of Pennsylvania · R01 · FY2025 · CA

IMPROVING PANCREATIC CANCER THERAPY THROUGH UNDERSTANDING AND EXPLOITING SAMHD1 IN DNA REPAIR

$617,542
Emory University · · FY2017 · Department of the Army

Validation of biomarkers for early diagnosis and risk prediction of pancreatic neoplasms

$617,452
Randall Brand · University Of Pittsburgh At Pittsburgh · U01 · FY2021 · CA

HIFU-immunotherapy in pancreatic cancer

$617,146
Katherine W Ferrara · Stanford University · R01 · FY2022 · CA

Multi-Parameter Monitoring of Breast Cancer Progression and Therapeutic Response

$616,625
Anna Moore · Massachusetts General Hospital · R01 · FY2008 · CA

The "dark immunopeptidome" as a source of CD8 T cell epitopes in type 1 diabetes

$616,624
Teresa P Dilorenzo · Albert Einstein College Of Medicine · R01 · FY2023 · DK

Deregulation of Sulfatide Synthesis in the Development and Progression of Pancreatic Cancer Precursor Lesions

$616,495
Johannes F Fahrmann · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA

Validation and Fine-Scale Mapping of Pancreatic Cancer Susceptibility Loci (Study)

$616,478
Alison P Klein · Johns Hopkins University · R01 · FY2019 · CA

In Vivo Base Editing for Precision Oncology Models

$616,320
Lukas Edward Dow · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · CA

Biomarkers for the Early Detection of Pancreatic Cancer

$616,200
Ann M Killary · University Of Tx Md Anderson Can Ctr · U01 · FY2010 · CA

Novel Approaches to Targeting Cancers Associated with VHL Mutations

$615,955
Ramaprasad Srinivasan · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Design and characterization of bacterial population dynamics in solid tumor models

$615,868
Jeff M Hasty · University Of California, San Diego · R01 · FY2024 · EB

Detecting cancer early with targeted nano-probes for vascular signatures

$615,856
Douglas Hanahan · University Of California, San Francisco · R01 · FY2009 · CA

Nrf2 Regulation of Ductal Pancreatic Cancer Etiology and Treatment Response

$615,683
David Tuveson · Cold Spring Harbor Laboratory · R01 · FY2021 · CA

Nrf2 Regulation of Ductal Pancreatic Cancer Etiology and Treatment Response

$615,683
David Tuveson · Cold Spring Harbor Laboratory · R01 · FY2018 · CA

Nrf2 Regulation of Ductal Pancreatic Cancer Etiology and Treatment Response

$615,683
David Tuveson · Cold Spring Harbor Laboratory · R01 · FY2020 · CA

Clinical Trials of Flavopiridol with Chemotherapy

$615,617
Sloan-Kettering Institute For Cancer Res · R01 · FY2005 · CA

Peptide-based targeted molecular imaging for early detection in pancreatic cancer

$615,523
Julie L Sutcliffe · University Of California At Davis · U01 · FY2019 · CA

Defining neoantigen immunodominance for antigen selection and biomarker discovery in human pancreatic cancer immunotherapy

$615,450
Vinod P Balachandran · Sloan-Kettering Inst Can Research · U01 · FY2020 · CA